Pear Therapeutics, Inc.

NASDAQ (USD): Pear Therapeutics, Inc. (PEARW)

Last Price

0.006

Today's Change

0.00 (0.00%)

Day's Change

0.005 - 0.007

Trading Volume

470,418

Profile
PEARW

Exchange:  NASDAQ Capital Market NASDAQ Capital Market

Currency:  USD USD

Sector:  Healthcare - Healthcare Healthcare - Healthcare

Industry: 

CEO:  Dr. Corey M. McCann M.D., Ph.D. Dr. Corey M. McCann M.D., Ph.D.

Full Time Employees:  200 200

IPO Date: 

CIK:  0001835567 0001835567

ISIN: 

CUSIP:  704723113 704723113

Beta:  0.00 0.00

Last Dividend:  0.00 0.00

Dcf Diff:  0.00 0.00

Dcf:  0.00 0.00

Description

Pear Therapeutics, Inc. engages in developing and commercializing software-based medicines. The company has a pipeline of products and product candidates across therapeutic areas, including severe psychiatric and neurologic conditions. Its products include PearConnect, a patient service center for prescription digital therapeutics; reSET for the treatment of substance use disorder; reSET-O for the treatment of opioid use disorder; and Somryst for the treatment of chronic insomnia. The company was founded in 2013 and is based in Boston, Massachusetts.

Address

200 State Street,
Boston, MA 02109, US

833 697 3738

http://peartherapeutics.com

Discussions
Be the first to like this. Showing 0 of 0 comments
Post a Comment